Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06501001

Time Restricted Eating (TRE) and High-Intensity Interval Training (HIIT) to Improve Health in Patients With Metabolic Syndrome (METS)

Time Restricted Eating and High-Intensity Interval Training to Improve Health in Patients With Metabolic Syndrome

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
University of Castilla-La Mancha · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Studies in mice provide compelling evidence that feeding/fasting cycles can be altered to produce beneficial effects on weight loss and cardiometabolic health markers in the absence of caloric restriction. Limited research in subjects with metabolic syndrome (MetS) suggests that this feeding paradigm may also apply to human health when combined with an exercise training program, but more research is needed to confirm this hypothesis. This project will determine the independent and combined effects of high-intensity interval training and time-restricted eating on cardiometabolic factors among overweight or obese patients with MetS. The intervention period will be sixteen weeks. Before and after the intervention, MetS components (i.e., MetS Z score), body composition, and physical fitness will be measured and compared between groups who are doing either high-intensity interval training, time-restricted eating, both high-intensity interval training and time-restricted eating, or who are in a control group. Physical activity, diet, sleep quality, and intervention adherence will also be measured.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHigh-Intensity Interval TrainingThree weekly, supervised exercise sessions with high intensity. Each session will last for 45 minutes. The intervention period will be sixteen weeks.
BEHAVIORALExperimental: Time-Restricted EatingRestricted daily window of caloric intake to a maximum 10 hours. The intervention period will be sixteen weeks.

Timeline

Start date
2024-09-01
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2024-07-15
Last updated
2025-12-02

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06501001. Inclusion in this directory is not an endorsement.